Insider · SEC Forms 3, 4, 5
CIK 1494730
All transactions
Every Form 4 row this person reported, newest first
Insider · SEC Forms 3, 4, 5
Every Form 4 row this person reported, newest first
Inrig Jula (CIK 1902368) reported 23 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-17). Recent activity: Buy TVTX (32,395 shares), Sell TVTX (25,390 shares), Sell TVTX (17,284 shares), Sell TVTX (1,600 shares), Sell TVTX (400 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-17 | Travere Therapeutics, Inc. (TVTX) | EVP, Head of R&D & CMO | Buy | 32,395 | $289,287 |
| 2026-09-17 | Travere Therapeutics, Inc. (TVTX) | EVP, Head of R&D & CMO | Sell | 25,390 | $1.6M |
| 2026-09-17 | Travere Therapeutics, Inc. (TVTX) | EVP, Head of R&D & CMO | Sell | 17,284 | $1.1M |
| 2026-09-17 | Travere Therapeutics, Inc. (TVTX) | EVP, Head of R&D & CMO | Sell | 1,600 | $101,896 |
| 2026-09-17 | Travere Therapeutics, Inc. (TVTX) | EVP, Head of R&D & CMO | Sell | 400 | $26,124 |
| 2026-06-22 | Travere Therapeutics, Inc. (TVTX) | CHIEF MEDICAL OFFICER | Sell | 468 | $0 |
| 2026-05-06 | Travere Therapeutics, Inc. (TVTX) | CHIEF MEDICAL OFFICER | Buy | 20,000 | $448,000 |
| 2026-05-06 | Travere Therapeutics, Inc. (TVTX) | CHIEF MEDICAL OFFICER | Sell | 20,000 | $900,000 |
| 2026-05-06 | Travere Therapeutics, Inc. (TVTX) | CHIEF MEDICAL OFFICER | Buy | 4,250 | $0 |
| 2026-05-06 | Travere Therapeutics, Inc. (TVTX) | CHIEF MEDICAL OFFICER | Sell | 2,174 | $101,417 |
| 2026-05-06 | Travere Therapeutics, Inc. (TVTX) | CHIEF MEDICAL OFFICER | Sell | 311 | $13,668 |
| 2026-04-15 | Travere Therapeutics, Inc. (TVTX) | CHIEF MEDICAL OFFICER | Buy | 14,000 | $0 |
| 2026-04-15 | Travere Therapeutics, Inc. (TVTX) | CHIEF MEDICAL OFFICER | Sell | 7,215 | $302,525 |
| 2026-04-15 | Travere Therapeutics, Inc. (TVTX) | CHIEF MEDICAL OFFICER | Sell | 1,018 | $43,377 |
| 2026-02-05 | Travere Therapeutics, Inc. (TVTX) | CHIEF MEDICAL OFFICER | Sell | 1,547 | $49,674 |
| 2026-02-05 | Travere Therapeutics, Inc. (TVTX) | CHIEF MEDICAL OFFICER | Sell | 232 | $7,621 |
| 2026-02-03 | Travere Therapeutics, Inc. (TVTX) | CHIEF MEDICAL OFFICER | Buy | 28,130 | $0 |
| 2026-02-03 | Travere Therapeutics, Inc. (TVTX) | CHIEF MEDICAL OFFICER | Sell | 6,956 | $223,427 |
| 2026-01-07 | Travere Therapeutics, Inc. (TVTX) | CHIEF MEDICAL OFFICER | Sell | 2,031 | $81,606 |
| 2026-01-07 | Travere Therapeutics, Inc. (TVTX) | CHIEF MEDICAL OFFICER | Sell | 445 | $16,799 |
| 2025-12-29 | Travere Therapeutics, Inc. (TVTX) | CHIEF MEDICAL OFFICER | Buy | 15,000 | $133,950 |
| 2025-12-29 | Travere Therapeutics, Inc. (TVTX) | CHIEF MEDICAL OFFICER | Sell | 15,000 | $630,000 |
| 2025-07-02 | Travere Therapeutics, Inc. (TVTX) | CHIEF MEDICAL OFFICER | Sell | 815 | $11,940 |
Source: SEC Form 4 filings · as of 2026-09-17